These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Use of tumor markers in the diagnosis of salivary gland tumors]. Seifert G Wien Klin Wochenschr; 1982 Jul; 94(14):372-5. PubMed ID: 6183837 [TBL] [Abstract][Full Text] [Related]
3. Markers of oral and salivary gland tumors: immunocytochemical investigations. Seifert G; Caselitz J Cancer Detect Prev; 1985; 8(1-2):23-34. PubMed ID: 2415254 [TBL] [Abstract][Full Text] [Related]
4. Tumor antigens in neoplasms of the human parotid gland. Caselitz J; Seifert G; Jaup T J Oral Pathol; 1982; 11(5):374-86. PubMed ID: 6183417 [TBL] [Abstract][Full Text] [Related]
5. Detection of tissue polypeptide antigen in salivary glands and salivary gland tumors. An immunohistochemical study. Caselitz J; Seifert G; Björklund B; Björklund V Appl Pathol; 1983; 1(2):115-20. PubMed ID: 6331474 [TBL] [Abstract][Full Text] [Related]
6. Amylase as an additional marker of salivary gland neoplasms. An immunoperoxidase study. Caselitz J; Seifert G; Grenner G; Schmidtberger R Pathol Res Pract; 1983 Mar; 176(2-4):276-83. PubMed ID: 6190154 [TBL] [Abstract][Full Text] [Related]
7. [Malignant salivary gland tumors. Effect of histology and site on prognosis]. Chilla R; Casjens R; Eysholdt U; Droese M HNO; 1983 Aug; 31(8):286-90. PubMed ID: 6629867 [TBL] [Abstract][Full Text] [Related]
8. The importance of tumor markers in oral pathology. II. Cell membrane and cytoplasmic antigens as tumour markers. Seifert G Pathol Res Pract; 1985 May; 179(6):625-8. PubMed ID: 4040631 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical distribution of CD9 in parotid gland tumors. Sakamoto K; Nakamura Y; Nakashima T Auris Nasus Larynx; 2004 Mar; 31(1):49-55. PubMed ID: 15041054 [TBL] [Abstract][Full Text] [Related]
10. Cell proliferation in salivary gland tumors. Skálová A; Leivo I Gen Diagn Pathol; 1996 Jun; 142(1):7-16. PubMed ID: 8793481 [TBL] [Abstract][Full Text] [Related]
11. Human kallikrein 6 expression in salivary gland tumors. Darling MR; Jackson-Boeters L; Daley TD; Diamandis EP J Histochem Cytochem; 2006 Mar; 54(3):337-42. PubMed ID: 16286664 [TBL] [Abstract][Full Text] [Related]
12. Salivary gland monomorphic adenoma. Ultrastructural, immunoperoxidase, and histogenetic aspects. Dardick I; Kahn HJ; Van Nostrand AW; Baumal R Am J Pathol; 1984 Jun; 115(3):334-48. PubMed ID: 6375388 [TBL] [Abstract][Full Text] [Related]
13. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260 [TBL] [Abstract][Full Text] [Related]
14. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Foschini MP; Marucci G; Eusebi V Virchows Arch; 2002 May; 440(5):536-42. PubMed ID: 12021929 [TBL] [Abstract][Full Text] [Related]
15. Lactoferrin and lysozyme in carcinomas of the parotid gland. A comparative immunocytochemical study with the occurrence in normal and inflamed tissue. Caselitz J; Jaup T; Seifert G Virchows Arch A Pathol Anat Histol; 1981; 394(1-2):61-73. PubMed ID: 6278702 [TBL] [Abstract][Full Text] [Related]